KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cineverse (CNVS) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Cineverse (CNVS) over the last 16 years, with Q4 2025 value amounting to $1.0 million.

  • Cineverse's Share-based Compensation rose 10959.18% to $1.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 million, marking a year-over-year increase of 3265.19%. This contributed to the annual value of $1.9 million for FY2025, which is 3377.35% up from last year.
  • Latest data reveals that Cineverse reported Share-based Compensation of $1.0 million as of Q4 2025, which was up 10959.18% from $494000.0 recorded in Q3 2025.
  • In the past 5 years, Cineverse's Share-based Compensation registered a high of $2.2 million during Q3 2022, and its lowest value of $183000.0 during Q4 2023.
  • In the last 5 years, Cineverse's Share-based Compensation had a median value of $559000.0 in 2023 and averaged $801550.0.
  • As far as peak fluctuations go, Cineverse's Share-based Compensation skyrocketed by 45536.72% in 2021, and later plummeted by 7745.72% in 2023.
  • Over the past 5 years, Cineverse's Share-based Compensation (Quarter) stood at $1.3 million in 2021, then tumbled by 47.52% to $708000.0 in 2022, then crashed by 74.15% to $183000.0 in 2023, then surged by 167.76% to $490000.0 in 2024, then skyrocketed by 109.59% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q4 2025, $494000.0 for Q3 2025, and $418000.0 during Q2 2025.